Re: Try this one
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 21, 2020 12:18PM
|
Re: Bioasis Announces Issuance of US Patent Relating to xB3 TM Platform Technology for The Delivery of Therapeutic Agents Across the Blood-Brain Barrier
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 21, 2020 12:15PM
|
Re: Try this one
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 21, 2020 12:08PM
|
Bioasis Announces Issuance of US Patent Relating to xB3 TM Platform Technology for The Delivery of Therapeutic Agents Across the Blood-Brain Barrier
|
|
BIOASIS TECHNOLOGIES INC
|
Oct 21, 2020 12:06PM
|
Re: The problem...as I see it
|
10
|
Resverlogix Corp.
|
Oct 20, 2020 10:28AM
|
Re: Upcoming Presentations
|
7
|
Resverlogix Corp.
|
Oct 19, 2020 03:00PM
|
Re: Re San fran
|
10
|
Resverlogix Corp.
|
Oct 19, 2020 11:30AM
|
Re: Zacks report on Bioasis
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 19, 2020 10:11AM
|
Re: The problem...as I see it
|
16
|
Resverlogix Corp.
|
Oct 19, 2020 08:18AM
|
Re: The problem...as I see it
|
15
|
Resverlogix Corp.
|
Oct 18, 2020 05:53PM
|
Re: Resverlogix Announces Presentations
|
6
|
Resverlogix Corp.
|
Oct 15, 2020 08:48AM
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
4
|
Resverlogix Corp.
|
Oct 14, 2020 05:18PM
|
Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
5
|
Resverlogix Corp.
|
Oct 14, 2020 05:17PM
|
Re: Bear
|
3
|
Zenith Epigenetics
|
Oct 09, 2020 05:23PM
|
Re: If anyone still cares about science...
|
7
|
Resverlogix Corp.
|
Oct 09, 2020 05:15PM
|
Resverlogix Announces $13 Million Private Placement
|
3
|
Resverlogix Corp.
|
Oct 06, 2020 09:47AM
|
Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 08:24AM
|
Resverlogix Confirms Interim Filings on SEDAR
|
3
|
Resverlogix Corp.
|
Oct 02, 2020 06:35PM
|
Re: Rules of thumb and broken thumbs...
|
9
|
Resverlogix Corp.
|
Sep 29, 2020 11:05AM
|
Re: Rules of thumb and broken thumbs...
|
3
|
Resverlogix Corp.
|
Sep 29, 2020 10:15AM
|